Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New bendable tube could make heart valve surgery safer

NCT ID NCT07320274

First seen Jan 09, 2026 · Last updated Jun 20, 2026 · Updated 27 times

Summary

This trial tests a new device called the ArcFlex Sheath, a bendable tube used during TAVR surgery to replace a faulty aortic valve. The goal is to see if it helps doctors position the new valve more easily and safely compared to a standard sheath. About 180 people who need TAVR surgery will take part. The study will measure how often the surgery is successful and track survival rates at 30 days and one year.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VALVE DISEASE, AORTIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The First Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

ArcFlex Sheath (a bendable tube used during heart valve replacement surgery)

What this could lead to

If it works, this could make TAVR heart valve surgery safer and more successful by helping doctors position the new valve more easily.

What could go wrong

This is an early-stage device trial with only 180 people, so results may not apply to everyone. There are always risks with any new surgical tool, such as damage to blood vessels.

Conditions

The condition(s) this trial relates to.

Aortic Valve Disease aortic valve disease 2

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.